We're committed to finding solutions to some of the biggest unmet therapeutic needs in #dementia, #SCI & #MultipleSclerosis. One of our principles is to cultivate passion: remembering the science we do is exciting, yet keeping the urgency needed to solve these critical problems.
What a great week at #BIO2024 in San Diego! We've loved meeting potential new collaborators & investors, as well as raising awareness of our work developing novel CNS therapeutics. We'd like to thank the @NIH for the invitation to present & @IAmBiotech for hosting the event.
Today is the start of #BIO2024 - an annual #biotech conference organised by the @IAmBiotech. @NovoronBio will be participating in a range of activities across the event. If you're also attending & would like to organise a time to chat, please get in touch!
novoron.com/news-events/novo…
We're proud to call San Diego home & committed to engaging in the thriving #startup & #biotech community that exists here. As such, we loved having our CEO, Dr. Travis Stiles, participate in the recent @SDRegionalEDC panel discussion on how to successfully grow small businesses.
We're excited to share that our CEO, Travis Stiles, & Chief of Staff, Kristien Van Vlasselaer, will be attending the @biocom Annual Global Partnering & Investor Conference. If you're participating in this event & would like to know more about @NovoronBio, please get in touch.
Our CEO, Travis Stiles, will be at the #JPM2024 meeting in San Francisco this week. If you're also attending this event & would like to organize a time to chat about our work on #remyelination, #spinalcordinjury or #tauopathies, please get in touch & we'll happily arrange a time.
A big year for @NovoronBio is coming to an end! We want to take this opportunity to thank all of our employees & collaborators for their hard work & support this year. We hope that you have a safe, happy & relaxing holiday period with your families & loved ones. #HappyHolidays
Having recently launched a research collaboration in Tasmania, it was great to meet @ScienceChiefAu at #BIO2023! Hearing more about the medical research ecosystem in Australia, we're excited about the research that we're doing & the potential to expand our presence "down under".
Thanks to Dr Rachel Kandel for this fantastic interview with our CEO, Dr Travis Stiles. The discussion captures much of the @NovoronBio journey: the past, the present and exciting news about our future! #neuroscience#biotechfoundingbio.substack.com/p/t…
Developing a therapy that promotes remyelination is a current goal of many #MultipleSclerosis researchers around the world. @MStranslate partner, Dr Travis Stiles, recently updated us on @NovoronBio’s work in this field. Learn more from him below. #MSyoutu.be/aLJ_MJs6kD0
We rarely post about topics that aren't related to our work, but sometimes it is important to do so. We want to extend our thoughts & well-wishes to the people of #Ukraine. War is never the answer and we hope #peace can soon be restored in the region. #StandWithUkraine
Understanding what stops the repair of damaged myelin in #MultipleSclerosis, and overcoming it, is a big part of our work. The more puzzle pieces that are found, the quicker we can progress. Fantastic work by all involved in this #research at @EdinburghUni.
We are very excited about collaborating with Assistant Prof. Rauch on this important project! Stay tuned - as we will make sure we provide some updates as they become available! @rauch1jn#Alzheimers#neuroscience#biotech